# Olopatadine Eye Drops and Allergy Skin Testing

> **NCT00775658** · NA · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 24 (actual)

## Conditions studied

- Allergic Rhinitis
- Allergic Conjunctivitis

## Interventions

- **DRUG:** olopatadine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00775658
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00775658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00775658, "Olopatadine Eye Drops and Allergy Skin Testing". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00775658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*